FCMI
Foresite Capital Management III Portfolio holdings
AUM
$37.9M
This Quarter Return
+11.3%
1 Year Return
-6.87%
3 Year Return
+443.49%
5 Year Return
+535.97%
10 Year Return
–
AUM
$356M
AUM Growth
+$356M
(-1.8%)
Cap. Flow
-$38.8M
Cap. Flow
% of AUM
-10.89%
Top 10 Holdings %
Top 10 Hldgs %
92.06%
Holding
21
New
1
Increased
5
Reduced
8
Closed
4
Top Buys
| 1 |
IMMU
Immunomedics Inc
IMMU
|
$5.18M |
| 2 |
AKAO
Achaogen, Inc.
AKAO
|
$4.97M |
| 3 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$2.85M |
| 4 |
Ascendis Pharma
ASND
|
$2.05M |
| 5 |
EPZM
Epizyme, Inc
EPZM
|
$1.86M |
Top Sells
| 1 |
Wave Life Sciences
WVE
|
$24.6M |
| 2 |
AIMT
Aimmune Therapeutics, Inc.
AIMT
|
$5.57M |
| 3 |
BPMC
Blueprint Medicines
BPMC
|
$5.1M |
| 4 |
LOXO
Loxo Oncology, Inc
LOXO
|
$4.61M |
| 5 |
Madrigal Pharmaceuticals
MDGL
|
$4.5M |
Sector Composition
| 1 | Healthcare | 39.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AERI
1
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $117M | 32.7% | 1,950,477 | – | – |
|
|
IMMU
2
DELISTED
Immunomedics Inc
IMMU
| $43.6M | 12.24% | 2,700,000 +320,633 | +13% | +$5.18M |
|
|
ALDR
3
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $32.6M | 9.15% | 2,847,130 -95,073 | -3% | -$1.09M |
|
|
BPMC
4
DELISTED
Blueprint Medicines
BPMC
| $30.2M | 8.46% | 400,000 -67,682 | -14% | -$5.1M |
|
|
AIMT
5
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $28.9M | 8.12% | 764,824 -147,177 | -16% | -$5.57M |
|
|
AKAO
6
DELISTED
Achaogen, Inc.
AKAO
| $25.5M | 7.16% | 2,375,000 +462,894 | +24% | +$4.97M |
|
|
7
Ascendis Pharma
ASND
$11.8B
| $13.5M | 3.78% | 336,264 +51,121 | +18% | +$2.05M |
|
|
MYOK
8
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $12.8M | 3.61% | 305,187 +10,187 | +3% | +$429K |
|
|
EPZM
9
DELISTED
Epizyme, Inc
EPZM
| $12.5M | 3.52% | 998,278 +148,585 | +17% | +$1.86M |
|
|
XLRN
10
DELISTED
Acceleron Pharma Inc.
XLRN
| $11.8M | 3.32% | 278,753 | – | – |
|
|
VRNA
11
Verona Pharma
VRNA
$9.16B
| $6.27M | 1.76% | 528,422 -80,429 | -13% | -$955K |
|
|
12
Wave Life Sciences
WVE
$1.53B
| $5.7M | 1.6% | 162,347 -700,980 | -81% | -$24.6M |
|
|
CBAY
13
DELISTED
Cymabay Therapeutics
CBAY
| $5.52M | 1.55% | 600,000 | – | – |
|
14
Aclaris Therapeutics
ACRS
$209M
| $5.25M | 1.47% | 212,950 -50,000 | -19% | -$1.23M |
|
|
BHVN
15
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $2.85M | 0.8% | +105,706 | New | +$2.85M |
|
16
Forte Biosciences
FBRX
$137M
| $1.52M | 0.43% | 148,552 -144,625 | -49% | -$1.48M |
|
17
Pacific Biosciences
PACB
$393M
| $1.18M | 0.33% | 447,520 -702,480 | -61% | -$1.85M |
|
18
argenx
ARGX
$43.6B
| – | – | -176,500 | Closed | -$3.99M |
|
|
19
Madrigal Pharmaceuticals
MDGL
$9.76B
| – | – | -100,000 | Closed | -$4.5M |
|
|
DERM
20
DELISTED
Dermira, Inc.
DERM
| – | – | -43,071 | Closed | -$1.16M |
|
|
LOXO
21
DELISTED
Loxo Oncology, Inc
LOXO
| – | – | -50,000 | Closed | -$4.61M |
|